Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 3 de 3
Filtrar
Mais filtros

Base de dados
Tipo de documento
Intervalo de ano de publicação
1.
Biol Trace Elem Res ; 2024 May 07.
Artigo em Inglês | MEDLINE | ID: mdl-38714633

RESUMO

The number of pollutants released into freshwater and marine environments has increased due to the widespread use of nanoparticles. Nickel oxide nanoparticles (NiO-NPs) were tested for genotoxicity in fish fingerlings of the species Ctenopharyngodon idella. For 7, 14, and 21 days, fingerlings were exposed to NiO-NPs with each increasing concentrations of 2.25 mg/L, 4.50 mg/L, and 6.75 mg/L, respectively. The micronuclei assay and comet assay were used to evaluate the DNA damage. The experiment revealed that with the increase in nanoparticle concentration and exposure duration, the level of DNA damage also increased. The experiment resulted to be time and dose dependent, and the damage was found as follows: 6.75 mg/L > 4.50 mg/L > 2.25 mg/L against each exposure period. In terms of comet assay, the results showed that after 7 days, the level of DNA damage in all the concentrations was highly significant (P < 0.001). Increased DNA damage was calculated at the higher administered dose of 6.75 mg/L for 21 days of exposition, followed by 14 and 7 days, respectively. The second high toxic effect was observed in the fish blood at the exposure concentration of 4.50 mg/L for 21 days, followed by 14 and 7 days, respectively. The micronuclei induction in the nanoparticle's administered blood could be detected only for a 7-day exposition period. Whereas for the exposed duration of 14 and 21 days, the entire red blood cells of the grass carp were completely destroyed demonstrating the ability of the nanoparticles to cause anomalies in aquatic life.

2.
Chemosphere ; 308(Pt 3): 136425, 2022 Dec.
Artigo em Inglês | MEDLINE | ID: mdl-36122750

RESUMO

Photocatalyst immobilization on support materials is essential for large-scale applications. Here, we describe growth of a p-n junction catalyst (NiO/TiO2) on a stainless-steel mesh (SSM) support using a facile hydrothermal method. The morphological superiority of the composite over previously reported NiO/TiO2 catalysts was probed using scanning and transmission electron microscopy. Flower petal-like NiO grew uniformly on SSM, which was evenly covered by TiO2 nanoparticles. Theoretical and experimental X-ray diffraction patterns were compared to analyze the development of the composite during various stages of synthesis. The photocatalytic activity of a powdered catalyst and SSM@catalyst was compared by measuring bisphenol A (BPA) degradation. SSM@NiO/TiO2 achieved the highest rate of BPA degradation, removing 96% of the BPA in 120 min. Scavenging experiments were used to investigate the charge separation and degradation mechanism. SSM@NiO/TiO2 showed excellent reusability potential, achieving and sustaining 91% BPA removal after 10 rounds of cyclic degradation. Reusability performance, composite resilience, apparent quantum yields, and figures of merit suggest that SSM@NiO/TiO2 has excellent utility for practical applications.


Assuntos
Compostos Benzidrílicos , Aço Inoxidável , Catálise , Fenóis , Titânio
3.
Cureus ; 11(9): e5779, 2019 Sep 27.
Artigo em Inglês | MEDLINE | ID: mdl-31723538

RESUMO

Cavernous transformation of the portal vein (CTPV), also known as portal cavernoma, is a sequelae of thrombosis in the portal vein causing its occlusion and portal hypertension. The etiology, however, remains unknown. Gastroesophageal variceal bleeding, splenomegaly, portosystemic collaterals, and ultimate hematologic abnormalities are among the prominent clinical features. Among the causes, predisposing an individual to CTPV is natural anticoagulant protein C and antithrombin III deficiencies. Determination of the etiology of CTPV may also give a direction toward the management plan to not only relieve the patient of the already developed complications but also to treat the primary cause of the pathology  We discuss a case of a nine-year-old male child diagnosed as CTPV secondary to protein C and antithrombin III deficiency who was treated symptomatically for anemia and varices and was referred for transjugular intrahepatic portosystemic shunt (TIPS).

SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA